NAMVANTAGE

Serial Number 99142731
686

Registration Progress

Application Filed
Apr 17, 2025
Under Examination
Approved for Publication
Dec 16, 2025
Published for Opposition
Dec 16, 2025
Registered

Trademark Image

NAMVANTAGE

Basic Information

Serial Number
99142731
Filing Date
April 17, 2025
Published for Opposition
December 16, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Dec 16, 2025
Application
Pending
Classes
042

Rights Holder

Simulations Plus, Inc.

03
Address
PO Box 12317
Research Triangle Park, NC 27709

Ownership History

Simulations Plus, Inc.

Original Applicant
03
Research Triangle Park, NC

Simulations Plus, Inc.

Owner at Publication
03
Research Triangle Park, NC

Legal Representation

Attorney
Bud Nelson

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Dec 16, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 16, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 10, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 19, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 17, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 17, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 17, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 6, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 6, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 6, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 11, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 11, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 17, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 17, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research, consultations, in the fields of research, discovery, and development of compounds being drugs or chemicals for others; In silico modeling services as an alternative to animal testing, namely scientific research, consultations, in the field of pharmacokinetics, pharmacodynamics, metabolism, absorption, distribution, quantitative systems pharmacology for compounds being drugs or chemicals for others; Scientific consulting services featuring adaptive learning services and predictive insights in the field of pharmaceutical product development to inform clinical trial design, optimize patient safety strategies, and support medical communications with data driven from mechanistic and human-relevant evidence for compounds being drugs or chemicals for others.

Classification

International Classes
042